Angela DeMichele Selected Research

Angela DeMichele Research Topics

Disease

126	Breast Neoplasms (Breast Cancer) 03/2024 - 03/2003
72	Neoplasms (Cancer) 03/2024 - 05/2003
10	Pathologic Complete Response 01/2022 - 01/2015
9	Arthralgia (Joint Pain) 03/2017 - 06/2009
6	Neutropenia 11/2023 - 04/2016
5	Neoplasm Metastasis (Metastasis) 02/2024 - 02/2012
5	Fatigue 10/2022 - 12/2014
4	Triple Negative Breast Neoplasms 01/2023 - 07/2016
4	Residual Neoplasm 01/2021 - 11/2003
4	Carcinogenesis 08/2018 - 01/2006
3	Pulmonary Arterial Hypertension 05/2024 - 01/2017
3	Heart Failure 01/2023 - 11/2003
3	Inflammation (Inflammations) 11/2022 - 08/2018
3	Anemia 11/2022 - 08/2018
3	Second Primary Neoplasms (Neoplasms, Second) 01/2022 - 01/2006
3	Cardiotoxicity 01/2022 - 11/2003
3	Disease Progression 11/2018 - 08/2017
3	Noninfiltrating Intraductal Carcinoma (DCIS) 06/2017 - 02/2007
3	Hot Flashes 11/2015 - 11/2003
3	Endometrial Neoplasms (Endometrial Cancer) 09/2008 - 09/2006
2	Pulmonary Hypertension 05/2024 - 01/2017
2	Overweight 11/2023 - 04/2012
2	Breast Ductal Carcinoma 07/2023 - 12/2022
2	Cardiomyopathies (Cardiomyopathy) 01/2023 - 11/2003
2	Ovarian Neoplasms (Ovarian Cancer) 11/2017 - 01/2009
2	Lymphedema (Milroy Disease) 10/2017 - 11/2010
2	Pain (Aches) 06/2015 - 09/2013
2	Peripheral Nervous System Diseases (PNS Diseases) 09/2013 - 10/2012
2	Osteoporosis 09/2008 - 11/2003

Drug/Important Bio-Agent (IBA)

40	Hormones (Hormone)IBA 03/2024 - 09/2006
25	Biomarkers (Surrogate Marker)IBA 07/2023 - 01/2006
21	Aromatase InhibitorsIBA 03/2024 - 06/2009
19	palbociclibIBA 03/2024 - 03/2015
14	Trastuzumab (Herceptin)FDA Link 01/2022 - 01/2013
13	ErbB Receptors (EGF Receptor)IBA 03/2024 - 11/2004
12	Fulvestrant (Faslodex)FDA Link 03/2024 - 04/2016
10	Estrogen ReceptorsIBA 01/2023 - 11/2003
8	AnthracyclinesIBA 01/2023 - 11/2003
7	Cyclin-Dependent Kinase 4IBA 03/2024 - 01/2017
7	Estrogens (Estrogen)FDA Link 01/2023 - 09/2006
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 02/2013
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 10/2016
6	human ERBB2 proteinIBA 11/2018 - 02/2012
5	Interleukin-6 (Interleukin 6)IBA 11/2022 - 11/2003
4	Cyclin-Dependent Kinases (cdk Proteins)IBA 03/2024 - 02/2016
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2021 - 01/2010
4	EnzymesIBA 07/2010 - 08/2005
3	Lapatinib (GW572016)FDA Link 01/2023 - 02/2012
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2023 - 02/2009
3	taxaneIBA 01/2022 - 05/2011
3	Hemoglobins (Hemoglobin)IBA 10/2021 - 04/2005
3	C-Reactive ProteinIBA 01/2021 - 06/2015
3	Retinoblastoma ProteinIBA 01/2020 - 03/2015
3	VaccinesIBA 06/2017 - 11/2007
3	Peptides (Polypeptides)IBA 06/2017 - 02/2007
3	inhibin BIBA 12/2014 - 02/2010
3	Anti-Mullerian HormoneIBA 12/2014 - 02/2010
3	salicylhydroxamic acid (SHAM)IBA 12/2014 - 01/2014
3	Vitamin D FDA LinkGeneric 06/2014 - 11/2003
3	Tamoxifen FDA LinkGeneric 09/2013 - 09/2008
3	Cytochrome P-450 CYP3AIBA 07/2010 - 08/2005
2	Anastrozole (Arimidex)FDA LinkGeneric 05/2024 - 01/2017
2	Epidermal Growth Factor (EGF)IBA 03/2023 - 11/2004
2	exemestane (Aromasin)FDA Link 11/2022 - 01/2021
2	ruxolitinibIBA 11/2022 - 08/2018
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2022 - 01/2020
2	pembrolizumabIBA 01/2022 - 01/2020
2	GlutaminaseIBA 01/2022 - 01/2021
2	Glutamine (L-Glutamine)FDA Link 01/2022 - 01/2021
2	Circulating Tumor DNAIBA 01/2022 - 08/2017
2	Everolimus FDA Link 01/2022 - 01/2021
2	Docetaxel (Taxotere)FDA Link 12/2021 - 02/2013
2	Phenobarbital (Luminal)FDA Link 10/2019 - 02/2016
2	neratinibIBA 01/2018 - 07/2016
2	MLN 8237IBA 11/2017 - 04/2015
2	Aurora Kinase AIBA 11/2017 - 04/2015
2	Cell-Free Nucleic AcidsIBA 08/2017 - 01/2017
2	CytokinesIBA 01/2017 - 01/2009
2	Carboplatin (JM8)FDA LinkGeneric 01/2017 - 07/2016
2	veliparibIBA 01/2017 - 07/2016
2	Complement System Proteins (Complement)IBA 05/2015 - 02/2007
2	Follicle Stimulating Hormone (Follitropin)FDA Link 12/2014 - 02/2010
2	Proteins (Proteins, Gene)FDA Link 02/2013 - 12/2012
2	MicroRNAs (MicroRNA)IBA 02/2013 - 05/2008
2	Tumor Biomarkers (Tumor Markers)IBA 09/2012 - 02/2009
2	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 03/2007 - 09/2006
1	Aromatase (CYP19)IBA 05/2024
1	avelumabIBA 03/2024
1	capivasertibIBA 03/2024
1	Uracil-DNA GlycosidaseIBA 02/2024
1	Epithelial Cell Adhesion MoleculeIBA 04/2023

Therapy/Procedure

65	Therapeutics 03/2024 - 11/2003
36	Drug Therapy (Chemotherapy) 11/2023 - 05/2003
25	Neoadjuvant Therapy 04/2023 - 04/2005
10	Adjuvant Chemotherapy 01/2020 - 05/2003
3	Electroacupuncture 11/2015 - 06/2009
2	Immunotherapy 01/2018 - 05/2012
2	Radiotherapy 11/2010 - 01/2006
2	Hormone Replacement Therapy (Therapy, Hormone Replacement) 02/2009 - 09/2006
2	Estrogen Replacement Therapy 10/2006 - 09/2006